TY - JOUR
T1 - Coverage and determinants of childhood immunization in Nigeria
T2 - A systematic review and meta-analysis
AU - Adeloye, Davies
AU - Jacobs, Wura
AU - Amuta, Ann O.
AU - Ogundipe, Oluwatomisin
AU - Mosaku, Oluwaseun
AU - Gadanya, Muktar A.
AU - Oni, Gbolahan
PY - 2017/5/19
Y1 - 2017/5/19
N2 - Introduction The proportion of fully immunized children in Nigeria is reportedly low. There are concerns over national immunization data quality, with this possibly limiting country-wide response. We reviewed publicly available evidence on routine immunization across Nigeria to estimate national and zonal coverage of childhood immunization and associated determinants. Methods A systematic search of Medline, EMBASE, Global Health and African Journals Online (AJOL) was conducted. We included population-based studies on childhood immunization in Nigeria. A random effects meta-analysis was conducted on extracted crude rates to arrive at national and zonal pooled estimates for the country. Results Our search returned 646 hits. 21 studies covering 25 sites and 26,960 children were selected. The estimated proportion of fully immunized children in Nigeria was 34.4% (95% confidence interval [CI]: 27.0–41.9), with South-south zone having the highest at 51.5% (95% CI: 20.5–82.6), and North-west the lowest at 9.5% (95% CI: 4.6–14.4). Mother's social engagements (OR = 4.0, 95% CI: 1.9–8.1) and vaccines unavailability (OR = 3.9, 95% CI: 1.2–12.3) were mostly reported for low coverage. Other leading determinants were vaccine safety concerns (OR = 3.0, 95% CI: 0.9–9.4), mother's low education (OR = 2.5, 95% CI: 1.8–3.6) and poor information (OR = 2.0, 95% CI: 0.8–4.7). Conclusion Our study suggests a low coverage of childhood immunization in Nigeria. Due to the paucity of data in the Northern states, we are still uncertain of the quality of evidence presented. It is hoped that this study will prompt the needed research, public health and policy changes toward increased evenly-spread coverage of childhood immunization in the country.
AB - Introduction The proportion of fully immunized children in Nigeria is reportedly low. There are concerns over national immunization data quality, with this possibly limiting country-wide response. We reviewed publicly available evidence on routine immunization across Nigeria to estimate national and zonal coverage of childhood immunization and associated determinants. Methods A systematic search of Medline, EMBASE, Global Health and African Journals Online (AJOL) was conducted. We included population-based studies on childhood immunization in Nigeria. A random effects meta-analysis was conducted on extracted crude rates to arrive at national and zonal pooled estimates for the country. Results Our search returned 646 hits. 21 studies covering 25 sites and 26,960 children were selected. The estimated proportion of fully immunized children in Nigeria was 34.4% (95% confidence interval [CI]: 27.0–41.9), with South-south zone having the highest at 51.5% (95% CI: 20.5–82.6), and North-west the lowest at 9.5% (95% CI: 4.6–14.4). Mother's social engagements (OR = 4.0, 95% CI: 1.9–8.1) and vaccines unavailability (OR = 3.9, 95% CI: 1.2–12.3) were mostly reported for low coverage. Other leading determinants were vaccine safety concerns (OR = 3.0, 95% CI: 0.9–9.4), mother's low education (OR = 2.5, 95% CI: 1.8–3.6) and poor information (OR = 2.0, 95% CI: 0.8–4.7). Conclusion Our study suggests a low coverage of childhood immunization in Nigeria. Due to the paucity of data in the Northern states, we are still uncertain of the quality of evidence presented. It is hoped that this study will prompt the needed research, public health and policy changes toward increased evenly-spread coverage of childhood immunization in the country.
KW - Childhood vaccination
KW - Nigeria
KW - Routine immunization
KW - Systematic reviews
UR - http://www.scopus.com/inward/record.url?scp=85018637321&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2017.04.034
DO - 10.1016/j.vaccine.2017.04.034
M3 - Review article
C2 - 28438406
AN - SCOPUS:85018637321
SN - 0264-410X
VL - 35
SP - 2871
EP - 2881
JO - Vaccine
JF - Vaccine
IS - 22
ER -